>
Importing Poverty into America: Devolving Our Nation into Stupid
Grand Theft World Podcast 273 | Goys 'R U.S. with Guest Rob Dew
Anchorage was the Receipt: Europe is Paying the Price… and Knows it.
The Slow Epstein Earthquake: The Rupture Between the People and the Elites
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
Starlink smasher? China claims world's best high-powered microwave weapon
Wood scraps turn 'useless' desert sand into concrete
Let's Do a Detailed Review of Zorin -- Is This Good for Ex-Windows Users?
The World's First Sodium-Ion Battery EV Is A Winter Range Monster
China's CATL 5C Battery Breakthrough will Make Most Combustion Engine Vehicles OBSOLETE

Retinitis pigmentosa (RP) is a genetic eye condition that results in damage to the retina. It has no cure; over time, a person with RP loses much or all of their vision.
But scientists have gotten one step closer to finding a better treatment. Researchers at the RIKEN Institute in Japan have now succeeded in growing retinal tissue and transplanting that tissue into the retinas of rhesus monkeys with RP. Three weeks after the treatment, visual tests on two of the monkeys found their vision had improved.
In the study, published this week in the journal PNAS, researchers grew retinal tissue from stem cells and then transplanted the tissue into the retinal area of rats with advanced RP. The tissue grew and in some cases adhered to the cells already in the retina and formed connections—a key factor in the success of this approach.